eurotimes.org

EuroTimes September 2017

Latest Supplements
EUROTIMES September 2017
Latest Issue


Latest Tweets @eurotimes
ESCRS Education Forum
  • Update on Toric IOLs – Rudy MMA Nuijts and Nino Hirnschall

    Toric IOLs have proven to be an excellent solution for higher levels of astigmatism. However, there are challenges in calculating the IOL power, challenges with the actual surgery. Dr Rudy Nuijts, of the University Eye Clinic Maastricht, the Netherlands, and Dr Nino Hirnschall, a researcher at the Vienna Institute for Research in Ocular Surgery, bring […]

    Wed 04 Apr 2018
  • Minimally invasive approaches to the orbit, facial structures – Jenny Yu

    Sean Henahan talks to Dr Jenny Yu, Vice Chair of Clinical Operations for the Department of Ophthalmology, University of Pittsburgh Eye Center about complications when dealing with the orbit, facial structures, and the skull base.

    Mon 12 Mar 2018
  • New drug delivery methods – Einar Stefánsson

    A fascinating area of research involves the development of innovative eye drop systems that could someday replace intravitreal injections. Jesper Hjortdal talks to a pioneer in the field, Dr Einar Stefánsson, about new approaches to ocular drug delivery.

    Mon 30 Apr 2018
  • Medical pre-treatment of the vascularised cornea before keratoplasty – Claus Cursiefen

    Corneal neovascularisation is a serious condition that can lead to a profound decline in vision. How can this problem best be managed? Sean Henahan talks to Claus Cursiefen.

    Tue 12 Jun 2018
  • IOL Power Calculation – Warren Hill

    Some 50 years after Fyodorov published the first paper on theoretical IOL power calculation, achieving an ideal patient outcome still remains a challenge. Dr Jaime Aramberri talks to Dr Warren Hill, Mesa, Arizona, US about  an innovative approach using artificial intelligence, the “Hill-radial basis function”.

    Wed 21 Mar 2018
  • Keratoconus: What We Have Accomplished And What Is Still Left To Do – François Malecaze

    Béatrice Cochener interviews François Malecaze, who delivered the EuCornea Medal lecture at the 8th EuCornea Congress in Lisbon, Portugal.

    Tue 15 May 2018
  • Long-term results in keratoplasty – Beatrice Frueh

    Penetrating keratoplasty was the original, and for a long time, the most common keratoplasty procedure. Professor Dan Epstein discusses the longer term results of keratoplasty with Professor Beatrice Frueh.

    Thu 24 May 2018
  • 50 years of phaco – Bekir Sitki Aslan

    Sean Henahan talks to Bekir Sitki Aslan, Head of Eye Department, Ankara Memorial Hospital, Turkey about what has changed 50 years after the introduction of phaco.

    Fri 15 Dec 2017
  • Glaucoma underdiagnosis and overdiagnosis – Fotis Topouzis

    It is challenging to identify patients with the early stages of the disease. But overenthusiastic screening could lead to other people receiving treatment who really don’t need it. Dr Ingeborg Stalmans talks with Dr Fotis Topouzis about glaucoma underdiagnosis and overdiagnosis.

    Tue 29 May 2018
  • Cataract surgery in high risk eyes – Boris Malyugin

    Sean Henahan interviews Boris Malyugin, who presented the Binkhorst Medal Lecture at the XXXV Congress of the ESCRS in Lisbon, Portugal, about the challenge of performing cataract surgery on eyes with small pupils. ESCRS members can watch Dr Malyugin’s lecture free on ESCRS on Demand.

    Fri 15 Jun 2018
  • New IOLS – Nino Hirnschall

    Modern monofocal IOL cataract surgery provides the vast majority of patients with very good visual results, for distance vision. Dr Nino Hirnschall, a researcher at the Vienna Institute for Research in Ocular Surgery, talks about some of the latest arrivals on the IOL scene.

    Wed 20 Jun 2018
  • Visual Retinal Image Quality – Raymond Applegate

    Quality of vision following any kind of refractive surgery matters most to patients. But how do we measure this, and how do evaluate the outcomes of various refractive surgical interventions in a comparative way? Marie-José Tassignon discusses this important topic with Dr Ray Applegate, of the University of Houston, Texas.

    Thu 26 Oct 2017